Failure of infused β-hydroxybutyrate to decrease proteolysis in man

J. M. Miles, S. L. Nissen, R. A. Rizza, J. E. Gerich, M. W. Haymond

Research output: Contribution to journalArticle

49 Scopus citations

Abstract

Ketone bodies have been suggested to have a protein-sparing effect, since infusion of Na-β-hydroxybutyrate in man decreases plasma alanine concentrations and urinary nitrogen (N) excretion. To test this hypothesis, 6 normal postabsorptive volunteers were infused with Na-β-hydroxybutyrate for 3 h. Rates of glucose, leucine carbon, and alanine appearance and disappearance from the plasma space were traced with [3- 3H]glucose, L-[6,6,6- 2H 3]leucine, and [2,3,3,3- 2H 4]alanine. Rates of leucine N appearance and disappearance and the rate of transfer of leucine N to alanine were assessed with [ 15N]leucine. During ketone body infusion, plasma alanine decreased (P < 0.05), whereas plasma leucine increased (P < 0.05). Rates of alanine appearance increased (5.3 ± 0.3 to 7.8 ± 0.6 μmol/kg . min), but the increase in its rate of disappearance was slightly greater, accounting for the decrease in plasma alanine concentration. Leucine N flux and the rate and percent of leucine N transferred to alanine increased, whereas leucine carbon flux was unchanged. To determine the effect of the alkalemia induced by Na-β-hydroxybutyrate, 4 additional subjects were infused with NaHCO 3. Alkalemia had no effect on leucine N or carbon flux or on the rate of appearance of alanine, but increased the rate of alanine disappearance, resulting in a decrease in the plasma alanine concentration. Since the rate of appearance of leucine carbon was unaltered during the infusion of Na-β-hydroxybutyrate, it is unlikely that hyperketonemia per se decreases proteolysis in postabsorptive man.

Original languageEnglish (US)
Pages (from-to)197-205
Number of pages9
JournalDiabetes
Volume32
Issue number3
StatePublished - Apr 7 1983

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Fingerprint Dive into the research topics of 'Failure of infused β-hydroxybutyrate to decrease proteolysis in man'. Together they form a unique fingerprint.

  • Cite this

    Miles, J. M., Nissen, S. L., Rizza, R. A., Gerich, J. E., & Haymond, M. W. (1983). Failure of infused β-hydroxybutyrate to decrease proteolysis in man. Diabetes, 32(3), 197-205.